Join the Non-Small Cell Lung Cancer group to help and get support from people like you.
Non-Small Cell Lung Cancer News
Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC
Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC
TUESDAY, April 22, 2025 – Prolonged disease control can be maintained for patients with advanced non-small cell lung cancer (NSCLC) who discontinue immune checkpoint inhibitors (ICIs) for...
Lung Cancer Remains At Bay Long After Immune Therapy Is Dropped
MONDAY, April 21, 2025 — Immunotherapy might help keep lung cancer at bay for months or even years after the treatment has been abandoned due to side effects, a new study says. Immune checkpoint i...
More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022
TUESDAY, April 1, 2025 – More than 3.8 million U.S. lung cancer deaths were averted during 1970 to 2022, and more than 76 million person-years of life were gained, according to a study published...
Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines
MONDAY, March 31, 2025 – Increased lung cancer screening uptake was seen after the 2021 update to the U.S. Preventive Services Task Force (USPSTF) guidelines, which expanded eligibility criteria to...
Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection
TUESDAY, March 25, 2025 – For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular residual disease (MRD) precedes disease-free...
New Guidelines Upped Lung Cancer Screenings, But Gaps Remain
MONDAY, March 24, 2025 – More smokers are getting CT screenings for lung cancer, thanks to guideline changes that included younger people and those who’ve smoked less, a new study says. However, s...
Lung Cancer Screening Adherence Rates Decline Annually After Baseline Screening
THURSDAY, March 20, 2025 – Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individuals undergoing lung cancer screening (LCS); however,...
Length of Stay After Lung Cancer Surgery Longer With Wildfire in County of Treating Facility
FRIDAY, March 14, 2025 – Patients with non-small cell lung cancer undergoing lobectomy or pneumonectomy whose treatment facility was in a U.S. county impacted by a wildfire disaster during recovery...
What Cancer Screenings Do You Need? A Quick Guide
SATURDAY, Feb. 15, 2025 – Cancer screenings can save lives by detecting cancer early, when treatment is most effective. With an estimated 2 million new cancer cases expected in 2025, regular...
Survival Improved With Lobectomy, Segmentectomy in Early NSCLC
TUESDAY, Jan. 28, 2025 – For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are associated with improved long-term survival...
Integrated Care Boosts Smoking Cessation When Undergoing Lung Cancer Screening
FRIDAY, Jan. 17, 2025 – Integrated care (IC) involving medication and intensive counseling provides the best opportunity for smoking cessation in the context of lung cancer screening (LCS),...
AI Can Guide Acquisition of Diagnostic-Quality Lung Ultrasound Images
FRIDAY, Jan. 17, 2025 – Trained health care professionals (THCPs), including medical assistants, respiratory therapists, and nurses, with artificial intelligence (AI) assistance can achieve lung...
Shifts in Trends Noted for Trachea, Bronchus, Lung Cancer Mortality
WEDNESDAY, Jan. 15, 2025 – Tobacco-associated trachea, bronchus, and lung (TBL) cancer mortality is declining, while ambient particulate matter (PM)-associated TBL cancer mortality is increasing,...
Rurality Partly Explains Racial Difference in Distance to Lung Cancer Screening
MONDAY, Jan. 13, 2025 – Differences in distance to lung cancer screening (LCS) facilities by race and ethnicity are partly explained by rurality, according to a study published online Jan. 14 in the...
FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
FRIDAY, Jan. 3, 2025 – The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid...